News
Research is Hope! Our interview with Dr. Jessic...
We are excited to introduce you to Jessica Lin, an Assistant Professor of Medicine at Harvard Medical School and a Clinical Assistant in Medicine, Hematology/Oncology at Massachusetts General Hospital. Dr....
Research is Hope! Our interview with Dr. Jessic...
We are excited to introduce you to Jessica Lin, an Assistant Professor of Medicine at Harvard Medical School and a Clinical Assistant in Medicine, Hematology/Oncology at Massachusetts General Hospital. Dr....
$300K Raised for RET-positive Cancer Research
We are thrilled to report 11 members of our extended RETpositive family raised over $300,000 to benefit RET-positive medical research. This generous funding was achieved through 658 individual gifts which have...
$300K Raised for RET-positive Cancer Research
We are thrilled to report 11 members of our extended RETpositive family raised over $300,000 to benefit RET-positive medical research. This generous funding was achieved through 658 individual gifts which have...
TAPISTRY (BO41932): Clinical trial for patients...
TAPISTRY (BO41932) is a Phase II, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in rational, specified...
TAPISTRY (BO41932): Clinical trial for patients...
TAPISTRY (BO41932) is a Phase II, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in rational, specified...
New collaborations set to attack RET driven non...
Exciting news from RETpositive and our partners at The Happy Lungs Project! This is a new initiative bringing together and funding several top institutions all across the US to work...
New collaborations set to attack RET driven non...
Exciting news from RETpositive and our partners at The Happy Lungs Project! This is a new initiative bringing together and funding several top institutions all across the US to work...
Survey Study: Help researchers understand the t...
Do you want to shape the future of lung cancer? We’re partnering with LUNGevity Foundation to learn about access to treatments and biomarker testing. By sharing your experience, you can...
Survey Study: Help researchers understand the t...
Do you want to shape the future of lung cancer? We’re partnering with LUNGevity Foundation to learn about access to treatments and biomarker testing. By sharing your experience, you can...
TROPION-LUNG01 trial showing good duration of r...
OncLive is reporting the preliminary research in the clinical trial for Trop2-ADC is looking promising. While not RET specific, for those that advance or do not respond to RET specific...
TROPION-LUNG01 trial showing good duration of r...
OncLive is reporting the preliminary research in the clinical trial for Trop2-ADC is looking promising. While not RET specific, for those that advance or do not respond to RET specific...